Helus Pharma Provides Update on APPROACH Phase 3 Trial Enrollment Progress
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/20/2026
- Wall Street gains ground on healthcare stocks rally, oil retreat
- Brent slips as Iran president discusses mediation with Pakistan army chief
- Loop Capital downgrades Apple, sees no recovery of cut iPhone shipments
- Wells Fargo says S&P 500 buy signal emerges as investors turn excessively bearish
- ByteDance, Alibaba and Tencent order $35 billion of Nvidia chips: Reuters
| (NASDAQ: HELP) | Delayed: 11.38 +0.69 (6.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.69 | 52 Week High | $ | |||
| Open | $10.75 | 52 Week Low | $ | |||
| Day High | $11.74 | P/E | N/A | |||
| Day Low | $10.67 | EPS | $ | |||
| Volume | 749,586 | |||||
